We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Perrysburg, Ohio, Feb. 05, 2025 (GLOBE NEWSWIRE) -- ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Can You Get Netflix for Free in Other Ways? Although Netflix doesn't have a free trial directly, you can still technically get free Netflix through other means. The only true "free" option ...

Eli Lilly has decided to wait for the readout of the second of its two phase 3 trials for tirzepatide in obesity ... Novo Nordisk's STEP trial programme for Wegovy revealed an average reduction ...

In November 2023, the Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for long-term weight management. Tirzepatide has been approved for treating type 2 diabetes under the trade ...

The internet user base in India is all set to surpass 900 million this year, according to the “Internet in India Report 2024,” jointly compiled by the Internet and Mobile Association of India (IAMAI) ...

The San Francisco 49ers and quarterback Brock Purdy are all but certain to reach an agreement on a lucrative contract this extension this offseason. The two parties have verbally committed to each ...

HashKey predicts Bitcoin could surpass $300,000, while Ethereum is expected to exceed $8,000. AI agents, Layer-2 solutions, STOs, and CBDCs will reshape technology, scalability, and financial inflows.

Enter GetSimpli Oral Tirzepatide, a revolutionary product that promises to transform your approach to weight loss and metabolic health. Unlike traditional weight loss methods that often involve ...

Netflix’s “Daredevil” has always held a special place as one of my all-time favorite shows, so admitting that Disney Plus’ “Daredevil: Born Again” might surpass it feels almost like ...

Goldman Sachs Group Inc. cruised past estimates as its equity traders delivered their best year on record. The firm’s fourth-quarter profits more than doubled to $4.1 billion, buoyed by strength ...